Frater Razes Marks 30 Years of Algerian Dedication at the 31st Algerian Production Fair

Published on: 2023-12-19 07:49

By: Hana Saada

Frater Razes Marks 30 Years of Algerian Dedication at the 31st Algerian Production Fair

BY: Hana Saada

ALGIERS- In an exclusive statement to Dzair Tube channel during the 31st Algerian Production Fair (Foire de la Production Algérienne – FPA), Yacine Laraba, Commercial Head at Frater Razes laboratories, underscored the company’s extensive history and deep-rooted commitment to the Algerian market.

Frater Razes proudly celebrates more than 30 years of steadfast engagement in the Algerian pharmaceutical landscape. Laraba emphasized the company’s enduring commitment to the local market, solidifying its position as a key player in the pharmaceutical industry.

In this vein, Laraba announced with pride that Frater Razes has been a significant contributor to healthcare in Algeria, manufacturing an extensive range of 135 medicines in its state-of-the-art laboratories. This diverse portfolio underscores the company’s dedication to addressing the healthcare needs of the Algerian population.

Local Expertise and Algerian Experience

Highlighting the paramount importance of local expertise, Laraba emphasized that Frater Razes’s success is intricately linked to its profound experience in Algeria. The company has seamlessly blended its pharmaceutical knowledge with a deep understanding of the Algerian healthcare landscape, resulting in the production of medicines finely tuned to meet the specific needs of the local population.

Throughout its three-decade journey, Frater Razes has consistently upheld high standards of quality in pharmaceutical manufacturing. Laraba stressed the company’s adherence to stringent quality control measures, ensuring that each medicine produced meets the highest international standards.

Community-Centric Engagement

Beyond its role as a pharmaceutical provider, Laraba expressed Frater Razes’s commitment to community well-being. The company actively engages with healthcare initiatives, contributing to the broader health and wellness of the Algerian population.

Frater Razes’s participation at the Algerian Production Fair stands as a testament to its enduring commitment, local integration, and pivotal role in shaping the pharmaceutical landscape of Algeria.

FRATER RAZES Laboratories: Pioneering Excellence and Shaping Algeria’s Pharmaceutical Landscape

FRATER RAZES Laboratories, founded by Dr. Abdelhamid Cherfaoui, stands as a trailblazer in Algeria’s pharmaceutical sector, leading with a commitment to autonomy and superior quality. Notably, the laboratory has achieved national self-sufficiency by producing an innovative anticoagulant derived from living cells, marking a significant milestone for the Algerian pharmaceutical industry.

Under the visionary leadership of Salah Eddine Khaled, FRATER RAZES played a pivotal role in crafting seven essential COVID-19 medicines amid global scarcity. The laboratory’s state-of-the-art facilities, adherence to international standards, and commitment to quality assurance have positioned it as a leader in the pharmaceutical landscape.

The laboratory’s diverse capabilities span production poles, including injected materials, technology, specialized dry materials, food supplements, and quality control. With over 800 internal control procedures and adherence to ISO 9001:2015 standards, FRATER RAZES prioritizes good manufacturing practices and quality management.

FRATER RAZES’ commitment extends beyond pharmaceutical excellence, with a dedicated focus on community well-being and environmental preservation. Recognized by the Minister of the Interior, the laboratory received investment certificates, reaffirming its pivotal role in advancing medical innovation and national prosperity.

As a regional leader, FRATER RAZES’ impact extends to 10 African countries and three Arab nations, contributing to healthcare solutions across borders. In the face of unprecedented challenges, the laboratory’s dedication to innovation, self-reliance, and collaborative progress sets a precedent in Algeria’s pharmaceutical landscape, aligning with strategic initiatives to diversify exports and reduce the import bill.

Dzair Tube Media Group

Dzair Tube has firmly established itself as a prominent player among Algerian digital news sites, offering a diverse and enriching content experience. The platform, available in Arabic, French, and English editions, captures the attention of a wide-ranging audience, amassing over half a million daily clicks.

A testament to its commitment to excellence, Dzair Tube received the prestigious President of the Republic’s Award for Professional Journalist in the Electronic Press category on October 22, 2022. This recognition underscores the platform’s unwavering dedication to upholding the highest standards of journalism.

With a significant online presence, Dzair Tube boasts 350,000 subscribers on YouTube, over five million followers on various Facebook pages, and 450,000 subscribers on Instagram. Its digital channel has become a hub for diverse programming, covering news, sports, entertainment, culture, and religion, catering to a broad spectrum of audience preferences.

Equipped with state-of-the-art studios and advanced technology, Dzair Tube’s digital channel has garnered substantial viewership for its varied programs. Hosting interactive discussions with influential figures across different domains, the platform actively fosters public discourse and engagement. Beyond news coverage, Dzair Tube extends its commitment to the production of marketing documentaries, short TV commercials, and high-viewership programs.

The success of the print edition of Dzair Tube’s sports newspaper, “Dzair Sport,” further highlights the platform’s impact, with over 50,000 daily downloads from the official Dzair Tube website.

Recently honored with the Media Leadership Award from the Minister of Communication, Mohamed Laâgab, Dzair Tube continues to shape the landscape of Algerian digital news, maintaining a position of influence and impact in the media industry.